Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

NCT05411835 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05411835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2022
Completion date
January 22, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carnitine palmitoyltransferase deficiency 2, long-chain 3-hydroxyacyl-coa dehydrogenase deficiency, trifunctional protein deficiency, very long chain acyl coa dehydrogenase deficiency